Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Czechia France Italy Poland Spain
  • Study of intraperitoneal chemotherapy (PIPAC) with cisplatin and doxorubicin combined with minimally invasive surgery in patients with high-risk gastric cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Denmark France Sweden
  • Study on [18F]FAPI-74 for Better Cancer Imaging in Patients with Esophagogastric and Pancreatic Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1
    Investigated drugs:
    Belgium France Germany Ireland Italy The Netherlands +3
  • Study of JK06 for Patients with Advanced or Metastatic Cancer

    Recruiting

    1 1
    Investigated drugs:
    Belgium Spain
  • Study on Pressurized Intraperitoneal Aerosol Chemotherapy with Fluorouracil for Patients with Gastric Cancer with Peritoneal Metastases

    Recruiting

    1 1 1 1
    Italy
  • Study on EXL01 with Nivolumab and FOLFOX for First-Line Treatment in Patients with PD-L1 CPS ≥5 Metastatic Gastric Cancer

    Recruiting

    1 1 1
    France
  • Study on the Effects of Rilvegostomig and Drug Combination for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Spain
  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Belgium France Germany Italy Spain
  • Study on the Effectiveness of Oxaliplatin, Docetaxel, and Fluorouracil in Patients with Resectable Gastric and Gastroesophageal Junction Cancer

    Recruiting

    1 1 1 1
    Germany